BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 8065405)

  • 1. Ovarian tumors in a cohort of infertile women.
    Rossing MA; Daling JR; Weiss NS; Moore DE; Self SG
    N Engl J Med; 1994 Sep; 331(12):771-6. PubMed ID: 8065405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of breast cancer in a cohort of infertile women.
    Rossing MA; Daling JR; Weiss NS; Moore DE; Self SG
    Gynecol Oncol; 1996 Jan; 60(1):3-7. PubMed ID: 8557223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovarian cancer risk after the use of ovulation-stimulating drugs.
    Brinton LA; Lamb EJ; Moghissi KS; Scoccia B; Althuis MD; Mabie JE; Westhoff CL
    Obstet Gynecol; 2004 Jun; 103(6):1194-203. PubMed ID: 15172852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of cutaneous melanoma in a cohort of infertile women.
    Rossing MA; Daling JR; Weiss NS; Moore DE; Self SG
    Melanoma Res; 1995 Apr; 5(2):123-7. PubMed ID: 7620340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In situ and invasive cervical carcinoma in a cohort of infertile women.
    Rossing MA; Daling JR; Weiss NS; Moore DE; Self SG
    Fertil Steril; 1996 Jan; 65(1):19-22. PubMed ID: 8557140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovarian epithelial neoplasia after hormonal infertility treatment: long-term follow-up of a historical cohort in Sweden.
    Sanner K; Conner P; Bergfeldt K; Dickman P; Sundfeldt K; Bergh T; Hagenfeldt K; Janson PO; Nilsson S; Persson I
    Fertil Steril; 2009 Apr; 91(4):1152-8. PubMed ID: 18371964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyroid cancer risk in women with infertility and association with fertility medications in Taiwan.
    Ding DC; Chen W; Wang JH; Lin SZ; Sung FC
    Cancer; 2019 May; 125(10):1701-1708. PubMed ID: 30645760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fertility drug use and risk of ovarian tumors: a debated clinical challenge.
    Gadducci A; Guerrieri ME; Genazzani AR
    Gynecol Endocrinol; 2013 Jan; 29(1):30-5. PubMed ID: 22946709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case-control study of ovarian cancer in relation to infertility and the use of ovulation-inducing drugs.
    Rossing MA; Tang MT; Flagg EW; Weiss LK; Wicklund KG
    Am J Epidemiol; 2004 Dec; 160(11):1070-8. PubMed ID: 15561986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infertility, ovulation induction treatments and the incidence of breast cancer--a historical prospective cohort of Israeli women.
    Lerner-Geva L; Keinan-Boker L; Blumstein T; Boyko V; Olmar L; Mashiach S; Rabinovici J; Potashnik G; Lunenfeld E; Schenker JG; Shushan A; Fishman A; Cohen I; Vagman I; Lunenfeld B
    Breast Cancer Res Treat; 2006 Nov; 100(2):201-12. PubMed ID: 16685587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovarian stimulation and borderline ovarian tumors: a case-control study.
    Mosgaard BJ; Lidegaard O; Kjaer SK; Schou G; Andersen AN
    Fertil Steril; 1998 Dec; 70(6):1049-55. PubMed ID: 9848294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fertility drug use and the risk of ovarian tumors in infertile women: a case-control study.
    Asante A; Leonard PH; Weaver AL; Goode EL; Jensen JR; Stewart EA; Coddington CC
    Fertil Steril; 2013 Jun; 99(7):2031-6. PubMed ID: 23552324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assisted reproductive technology and risk of ovarian cancer and borderline tumors in parous women: a population-based cohort study.
    Lundberg FE; Johansson ALV; Rodriguez-Wallberg K; Gemzell-Danielsson K; Iliadou AN
    Eur J Epidemiol; 2019 Nov; 34(11):1093-1101. PubMed ID: 31377935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk for borderline ovarian tumours after exposure to fertility drugs: results of a population-based cohort study.
    Bjørnholt SM; Kjaer SK; Nielsen TS; Jensen A
    Hum Reprod; 2015 Jan; 30(1):222-31. PubMed ID: 25376453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clomiphene and other antioestrogens for ovulation induction in polycystic ovarian syndrome.
    Brown J; Farquhar C
    Cochrane Database Syst Rev; 2016 Dec; 12(12):CD002249. PubMed ID: 27976369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer risk associated with ovulation-stimulating drugs.
    Brinton LA; Scoccia B; Moghissi KS; Westhoff CL; Althuis MD; Mabie JE; Lamb EJ
    Hum Reprod; 2004 Sep; 19(9):2005-13. PubMed ID: 15217997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant tumors of the ovary or the breast in association with infertility: a report of thirteen cases.
    Unkila-Kallio L; Leminen A; Tiitnen A; Lehtovirta P; Wahlström T; Ylikorkala O
    Acta Obstet Gynecol Scand; 1997 Feb; 76(2):177-81. PubMed ID: 9049294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of breast cancer in women treated with ovarian stimulation drugs for infertility: a systematic review and meta-analysis.
    Beebeejaun Y; Athithan A; Copeland TP; Kamath MS; Sarris I; Sunkara SK
    Fertil Steril; 2021 Jul; 116(1):198-207. PubMed ID: 34148584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer incidence in a cohort of infertile women.
    Modan B; Ron E; Lerner-Geva L; Blumstein T; Menczer J; Rabinovici J; Oelsner G; Freedman L; Mashiach S; Lunenfeld B
    Am J Epidemiol; 1998 Jun; 147(11):1038-42. PubMed ID: 9620047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovulation induction treatment and risk of borderline ovarian tumors.
    Cusidó M; Fábregas R; Pere BS; Escayola C; Barri PN
    Gynecol Endocrinol; 2007 Jul; 23(7):373-6. PubMed ID: 17701767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.